Walleye Trading’s HOOKIPA Pharma HOOK Stock Holding History

Walleye Trading’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-5,767	Closed	-$134K	–	5546
2021 Q4	$134K	Buy	5,767 +3,503	+155%	+$141K	﹤0.01%	4213
2021 Q3	$133K	Buy	+2,264	New	+$164K	﹤0.01%	4202

Other funds holding HOOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Walleye Trading's HOOK Position: Q1 2022 in Review

Walleye Trading sold out of HOOKIPA Pharma (HOOK) in Q1 2022, closing a stake of 5,767 shares — an estimated $134K sold.

Walleye Trading first reported a position in HOOK in Q3 2021 and held it in 2 quarters. The position peaked at $134K in Q4 2021. 74 funds tracked by Wall St. Rank hold HOOK as of Q1 2022.

Walleye Trading reported no remaining HOOKIPA Pharma position as of Q1 2022 after selling out during the quarter.
Walleye Trading sold 5,767 HOOKIPA Pharma shares in Q1 2022, an estimated $134K.
Walleye Trading first reported a position in HOOKIPA Pharma in Q3 2021 and held it in 2 quarters.
Walleye Trading's HOOKIPA Pharma position peaked at $134K in Q4 2021.
74 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2022.

Based on Walleye Trading's 13F filing for Q1 2022, filed 16 May 2022.